» Articles » PMID: 32602202

Obesity As a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study

Overview
Date 2020 Jul 1
PMID 32602202
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to explore the indicators for severity of coronavirus disease 2019 (COVID-19) in young patients between the ages of 18 and 40 years.

Methods: This retrospective cohort study included 65 consecutively admitted patients with COVID-19 who were between 18 and 40 years old in Zhongnan Hospital of Wuhan University in Wuhan, China. Among them, 53 were moderate cases, and 12 were severe or critical cases. Epidemiological, clinical, and laboratory characteristics and treatment data were collected. A multivariate logistic regression analysis was implemented to explore risk factors.

Results: The patients with severe/critical cases had obviously higher BMI (average 29.23 vs. 22.79 kg/m ) and lower liver computed tomography value (average 50.00 vs. 65.00 mU) than the group of moderate cases. The patients with severe/critical cases had higher fasting glucose, alanine aminotransferase, aspartate aminotransferase, and creatinine compared with patients with moderate cases (all P < 0.01). More severe/critical cases (58.33% vs. 1.92%) had positive urine protein levels. The severe/critical cases also experienced a significant process of serum albumin decline. Logistic regression analysis showed that male sex, high BMI (especially obesity), elevated fasting blood glucose, and urinary protein positivity were all risk factors for young patients with severe COVID-19.

Conclusions: Obesity is an important predictor of COVID-19 severity in young patients. The main mechanism is related to damage of the liver and kidney.

Citing Articles

Gastrointestinal Manifestations and Outcomes of COVID-19: A Comprehensive Systematic Review and Meta-analysis.

Mehta D, Kelkar R, Patel N, Trivedi P, Dawoodi S, Patel D Cureus. 2023; 15(10):e47028.

PMID: 37965386 PMC: 10642711. DOI: 10.7759/cureus.47028.


Prevalence and Determinants of Long COVID Among Patients Attending the Outpatient Department of a Subdistrict Hospital in Haryana.

Salve H, Daniel R, Kumar A, Kumar R, Misra P Cureus. 2023; 15(9):e46007.

PMID: 37900449 PMC: 10602202. DOI: 10.7759/cureus.46007.


Metabolic Associated Fatty Liver Disease (MAFLD) and COVID-19 Infection: An Independent Predictor of Poor Disease Outcome?.

Milivojevic V, Bogdanovic J, Babic I, Todorovic N, Rankovic I Medicina (Kaunas). 2023; 59(8).

PMID: 37629728 PMC: 10456234. DOI: 10.3390/medicina59081438.


Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.

Shrestha M, Basnet A, Tamang B, Khadka S, Maharjan R, Maharjan R PLoS One. 2023; 18(8):e0287117.

PMID: 37540679 PMC: 10403103. DOI: 10.1371/journal.pone.0287117.


Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2-Review of the Evidence.

Boleslawska I, Kowalowka M, Boleslawska-Krol N, Przyslawski J Viruses. 2023; 15(6).

PMID: 37376562 PMC: 10326824. DOI: 10.3390/v15061262.


References
1.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

2.
Fuse K, Kadota A, Kondo K, Morino K, Fujiyoshi A, Hisamatsu T . Liver fat accumulation assessed by computed tomography is an independent risk factor for diabetes mellitus in a population-based study: SESSA (Shiga Epidemiological Study of Subclinical Atherosclerosis). Diabetes Res Clin Pract. 2020; 160:108002. DOI: 10.1016/j.diabres.2020.108002. View

3.
Iacobellis G, Penaherrera C, Bermudez L, Mizrachi E . Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Res Clin Pract. 2020; 164:108185. PMC: 7251996. DOI: 10.1016/j.diabres.2020.108185. View

4.
Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L . A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020; 71(15):833-840. PMC: 7184338. DOI: 10.1093/cid/ciaa443. View

5.
Gigante A, Barbano B, Sardo L, Martina P, Gasperini M, Labbadia R . Hypercoagulability and nephrotic syndrome. Curr Vasc Pharmacol. 2012; 12(3):512-7. DOI: 10.2174/157016111203140518172048. View